Discussion in 'Trading' started by rowenwood, Dec 29, 2003.
buy NUVO early monday
Because some idiot owns a few shares, is bullish on it, and has to start a new thread to tell everybody.
Eyes wide open people:
Return on Assets (ttm): -129.60%
Return on Equity (ttm): -495.29%
Revenue (ttm): 26.43M
Revenue Per Share (ttm): 0.109
Revenue Growth (lfy)Â³: 7.50%
Gross Profit (ttm)Â²: 26.43M
EBITDA (ttm): -56.68M
Net Income Avl to Common (ttm): -57.31M
Diluted EPS (ttm): -1.427
Earnings Growth (lfy)Â³: N/A
Total Cash (mrq): 18.37M
Total Cash Per Share (mrq): 0.24
Total Debt (mrq)Â²: 21.21M
Total Debt/Equity (mrq): 4.342
Current Ratio (mrq): 0.781
Book Value Per Share (mrq): 0.08
Cash Flow Statement
From Operations (ttm)Â³: -41.37M
Free Cashflow (ttm)Â³: -41.83M
And I love the price/sales ratio of 46.62...
I'm all over it, first thing on the list for Monday am. No news is good news, right??
Seriously, the chart actually looks like it might run up a bit.
I'm not going near this one buy somehow I don't think this guy was telling you to buy it on fundamentals.
last three weeks you're a loser. Making money in this market environment is as easy as....
I'm not going mention my current positions. My attitude lately is, if I don't earn a minimum of 5% a week I'm doing something wrong.
I sold NUVO at 4.30 per about two weeks ago. On to the next 100% increase. I'm heavily margined, and making highly risky decisions on biotech stocks as usual. But maybe these decisions are not so risky. I have only to pick one winning trade out of every five in order to be profitable. I've increased my portfolion by so many percentage points that losing all my profits would require ten or more bad trades in a row.
Day trading is an overrated joke, not that I've tried it more than once. I dislike the way daytraders affect stock prices. Day trading is trendy and apparently the riskiest form of stock investing. It's funny how many dts think they're not gamblers.
Separate names with a comma.